Hanjoon Alex Kim - 22 May 2025 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
Chief Financial Officer
Signature
/s/ Hanjoon Alex Kim by Tomone Tanaka, Attorney-in-Fact
Issuer symbol
LAB
Transactions as of
22 May 2025
Net transactions value
-$1,358
Form type
4
Filing time
27 May 2025, 20:33:14 UTC
Previous filing
22 May 2025
Next filing
28 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kim Hanjoon Alex Chief Financial Officer C/O STANDARD BIOTOOLS INC., 2 TOWER PLACE, STE 2000, SOUTH SAN FRANCISCO /s/ Hanjoon Alex Kim by Tomone Tanaka, Attorney-in-Fact 27 May 2025 0001919209

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Sale $1,358 -1,355 -0.15% $1.00 931,714 22 May 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to satisfy the tax obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission ("SEC") on March 24, 2025.
F2 Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9403 to $1.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.